Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|March 13, 2003
New approaches to reversal of neuromuscular blockAnton Bom, John K Clark, Ronald PalinBioorganic & Medicinal Chemistry|February 6, 2008
Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic propertiesRonald Palin, John K Clark, Louise Evans, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Novel piperidinium and pyridinium agents as water-soluble acetylcholinesterase inhibitors for the reversal of neuromuscular blockadeRonald Palin, John K Clark, Phill Cowley, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Quaternary salts of E2020 analogues as acetylcholinesterase inhibitors for the reversal of neuromuscular blockJohn K Clark, Phill Cowley, Alan W Muir, et al.Bioorganic & Medicinal Chemistry|December 15, 2006
Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative propertiesRonald Palin, Anton Bom, John K Clark, et al.Carbon Balance and Management|February 1, 2012
Human and environmental controls over aboveground carbon storage in MadagascarGregory P Asner, John K Clark, Joseph Mascaro, et al.Bioorganic & Medicinal Chemistry Letters|February 22, 2011
Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonistsPhillip M Cowley, James Baker, Kirsteen I Buchanan, et al.Proceedings of the National Academy of Sciences of the United States of America|September 9, 2010
High-resolution forest carbon stocks and emissions in the AmazonGregory P Asner, George V N Powell, Joseph Mascaro, et al.Journal of Medicinal Chemistry|April 19, 2002
Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationshipsJulia M Adam, D Jonathan Bennett, Anton Bom, et al.Bioorganic & Medicinal Chemistry Letters|October 13, 2009
Rapid access towards follow-up NOP receptor agonists using a knowledge based approachRonald Palin, John K Clark, Louise Evans, et al.Pageof 2